Bowen Hanes & Co’s Cardinal Health CAH Stock Holding History

Bowen Hanes & Co’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,200	Closed	-$321K	–	149
2018 Q4	$321K	Buy	+7,200	New	+$375K	0.02%	152

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bowen Hanes & Co's CAH Position: Q1 2019 in Review

Bowen Hanes & Co sold out of Cardinal Health (CAH) in Q1 2019, closing a stake of 7,200 shares — an estimated $321K sold.

Bowen Hanes & Co first reported a position in CAH in Q4 2018 and held it in 1 quarter. The position peaked at $321K in Q4 2018. 693 funds tracked by Wall St. Rank hold CAH as of Q1 2019.

Bowen Hanes & Co reported no remaining Cardinal Health position as of Q1 2019 after selling out during the quarter.
Bowen Hanes & Co sold 7,200 Cardinal Health shares in Q1 2019, an estimated $321K.
Bowen Hanes & Co first reported a position in Cardinal Health in Q4 2018 and held it in 1 quarter.
Bowen Hanes & Co's Cardinal Health position peaked at $321K in Q4 2018.
693 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2019.

Based on Bowen Hanes & Co's 13F filing for Q1 2019, filed 13 May 2019.